SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-218802
Filing Date
2018-07-16
Accepted
2018-07-16 16:47:35
Documents
5
Period of Report
2018-07-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d510012d8k.htm 8-K 17551
2 EXHIBIT 10.1 d510012dex101.htm EX-10.1 4986
3 EXHIBIT 99.1 d510012dex991.htm EX-99.1 8277
4 GRAPHIC g510012g09d53.jpg GRAPHIC 4595
5 GRAPHIC g510012gra1.jpg GRAPHIC 9383
  Complete submission text file 0001193125-18-218802.txt   51720
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 18954838
SIC: 2834 Pharmaceutical Preparations